Your browser doesn't support javascript.
loading
Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.
Chuluundorj, Delgertsetseg; Harding, Scott A; Abernethy, David; La Flamme, Anne Camille.
Affiliation
  • Chuluundorj D; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
  • Harding SA; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
  • Abernethy D; Cardiology Department, Wellington Regional Hospital, Wellington, New Zealand.
  • La Flamme AC; Cardiology Department, Wellington Regional Hospital, Wellington, New Zealand.
Immunol Cell Biol ; 95(3): 297-305, 2017 03.
Article in En | MEDLINE | ID: mdl-27694998
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Glatiramer Acetate / Multiple Sclerosis Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2017 Document type: Article Affiliation country: Nueva Zelanda Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Glatiramer Acetate / Multiple Sclerosis Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2017 Document type: Article Affiliation country: Nueva Zelanda Country of publication: Estados Unidos